Clinical Trial Update: A Study of Oral Ergocalciferol to Treat Pruritis in Hemodialysis Patients [Phase 4]

View source ↗

Summary

A phase 4 study evaluated oral ergocalciferol for treating pruritus in hemodialysis patients; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease-associated Pruritus

Drugs mentioned

• ergocalciferol (ergocalciferol)

Snippet

Sponsor: Winthrop University Hospital | Conditions: Pruritis | Phase 4 | Status: COMPLETED | Results posted: 2013-02-12